Risks of breast or ovarian cancer in BRCA1 or BRCA2 predictive test negatives: findings from the EMBRACE study

PURPOSE: BRCA1/BRCA2 predictive test negatives are proven noncarriers of a BRCA1/BRCA2 mutation that is carried by their relatives. The risk of developing breast cancer (BC) or epithelial ovarian cancer (EOC) in these women is uncertain. The study aimed to estimate risks of invasive BC and EOC in a...

Descripción completa

Detalles Bibliográficos
Autores principales: Girardi, Fabio, Barnes, Daniel R, Barrowdale, Daniel, Frost, Debra, Brady, Angela F, Miller, Claire, Henderson, Alex, Donaldson, Alan, Murray, Alex, Brewer, Carole, Pottinger, Caroline, Evans, D Gareth, Eccles, Diana, Lalloo, Fiona, Gregory, Helen, Cook, Jackie, Eason, Jacqueline, Adlard, Julian, Barwell, Julian, Ong, Kai Ren, Walker, Lisa, Izatt, Louise, Side, Lucy E, Kennedy, M John, Tischkowitz, Marc, Rogers, Mark T, Porteous, Mary E, Morrison, Patrick J, Eeles, Ros, Davidson, Rosemarie, Snape, Katie, Easton, Douglas F, Antoniou, Antonis C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group US 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6033314/
https://www.ncbi.nlm.nih.gov/pubmed/29565421
http://dx.doi.org/10.1038/gim.2018.44

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6033314/
https://www.ncbi.nlm.nih.gov/pubmed/29565421
http://dx.doi.org/10.1038/gim.2018.44

Ejemplares similares